JP2025500787A5 - - Google Patents

Info

Publication number
JP2025500787A5
JP2025500787A5 JP2024534233A JP2024534233A JP2025500787A5 JP 2025500787 A5 JP2025500787 A5 JP 2025500787A5 JP 2024534233 A JP2024534233 A JP 2024534233A JP 2024534233 A JP2024534233 A JP 2024534233A JP 2025500787 A5 JP2025500787 A5 JP 2025500787A5
Authority
JP
Japan
Prior art keywords
optionally substituted
item
pyridine
compound
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534233A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500787A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/052224 external-priority patent/WO2023107603A1/en
Publication of JP2025500787A publication Critical patent/JP2025500787A/ja
Publication of JP2025500787A5 publication Critical patent/JP2025500787A5/ja
Pending legal-status Critical Current

Links

JP2024534233A 2021-12-08 2022-12-08 ピリミジンおよびその使用方法 Pending JP2025500787A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163287479P 2021-12-08 2021-12-08
US63/287,479 2021-12-08
PCT/US2022/052224 WO2023107603A1 (en) 2021-12-08 2022-12-08 Pyrimidines and methods of their use

Publications (2)

Publication Number Publication Date
JP2025500787A JP2025500787A (ja) 2025-01-15
JP2025500787A5 true JP2025500787A5 (https=) 2025-12-10

Family

ID=86731181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534233A Pending JP2025500787A (ja) 2021-12-08 2022-12-08 ピリミジンおよびその使用方法

Country Status (9)

Country Link
US (1) US20250197375A1 (https=)
EP (1) EP4444309A4 (https=)
JP (1) JP2025500787A (https=)
KR (1) KR20240133710A (https=)
CN (1) CN118922188A (https=)
AU (1) AU2022407039A1 (https=)
CA (1) CA3240381A1 (https=)
MX (1) MX2024007010A (https=)
WO (1) WO2023107603A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025005744A1 (ko) * 2023-06-29 2025-01-02 (주)아이젠사이언스 신규 피리미딘 유도체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA013811B1 (ru) * 2002-11-21 2010-08-30 Новартис Вэксинес Энд Дайэгностикс, Инк. 2,4,6-тризамещённые пиримидины, являющиеся ингибиторами фосфотидилинозитол(pi)-3-киназы, и их применение при лечении рака
CA2531619A1 (en) * 2003-07-16 2005-01-27 Neurogen Corporation Biaryl piperazinyl-pyridine analogues
JO2660B1 (en) * 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
EP2050749B1 (en) * 2006-08-08 2017-11-22 Chugai Seiyaku Kabushiki Kaisha Pyrimidine derivative as pi3k inhibitor and use thereof
GB2465405A (en) * 2008-11-10 2010-05-19 Univ Basel Triazine, pyrimidine and pyridine analogues and their use in therapy
CN107922354B (zh) * 2015-05-07 2021-05-25 苏州韬略生物科技有限公司 作为idh2抑制剂的杂环化合物
WO2017040971A1 (en) * 2015-09-03 2017-03-09 Biomarin Pharmaceutical Inc. Methods of using inhibitors of pikfyve for the treatment of lysosomal storage disorders and neurodegenerative diseases
TW202134245A (zh) * 2019-12-05 2021-09-16 美商邊際分析公司 稠合三環雜環化合物及其用途
EP4103281A1 (en) * 2020-02-11 2022-12-21 Acurastem Inc. Pikfyve kinase inhibitors

Similar Documents

Publication Publication Date Title
JP7169412B2 (ja) 抗癌活性及び抗増殖活性を呈する2-アミノピリミジン-6-オン及び類似体
AU2018282363B2 (en) Compounds and methods of use
JP2022185107A5 (https=)
CN106518924B (zh) 用于治疗nk-1受体相关疾病的取代的4-苯基吡啶
JP5965923B2 (ja) プロテインキナーゼ阻害剤としてのリン含有化合物
CN114430739A (zh) Egfr抑制剂、组合物及其制备方法
TWI690525B (zh) 具有四氫吡喃基甲基之吡啶酮衍生物及其用途
JP2024523839A5 (https=)
JP2021513967A5 (https=)
JP2019533694A5 (https=)
JP2022505525A5 (https=)
JP2005530722A5 (https=)
RU2010125220A (ru) Ненуклеозидные ингибиторы обратной транскриптазы
DK131893A (da) 2-(Substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk præparat, som indeholder sådanne samt anvendelse af en sådan forbindelse til fremstilling af et farmaceutisk præparat
JP2020527173A5 (https=)
JP2017502033A5 (https=)
IL256191A (en) New amino acid histories, the process for their preparation and the pharmaceutical preparations that contain them
CA2605738A1 (en) Novel azaheterocyclic compounds as kinase inhibitors
CA2418868A1 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
CA2519898A1 (en) Oral administration of cyclic protein tyrosine kinase inhibitors
TW201249823A (en) Tetrasubstituted cyclohexyl compounds as kinase inhibitors
JP2021501756A5 (https=)
JP6380777B2 (ja) PI3K、mTOR阻害薬としての縮合キノリン化合物
RU2012114846A (ru) Соединение глицина
RU2018131775A (ru) 6-арил-4-морфолин-1-илпиридоны, пригодные для лечения рака или диабета